|Bid||24.20 x 1100|
|Ask||24.38 x 1200|
|Day's Range||24.02 - 25.12|
|52 Week Range||12.63 - 26.60|
|Beta (5Y Monthly)||1.47|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec. 09, 2015|
|1y Target Est||N/A|
Joining me today from CryoLife management team are Pat Mackin, CEO; and Ashley Lee, CFO. Comments made on this call that look forward in time involve risks and uncertainties and are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements include statements made as to the Company's or management's intentions, hopes, beliefs, expectations or predictions of the future.
CryoLife (CRY) delivered earnings and revenue surprises of 1100.00% and 4.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...